Comparison of pharmacokinetic parameters of intravenous quinidine and quinine in dogs. 1982

D R Clohisy, and T P Gibson

The pharmacokinetic parameters of quinidine and quinine were determined and compared in seven mongrel dogs. Both drugs were given intravenously, with a minimum of 4 weeks between protocols, and blood samples collected for 20-24 h. Depending on the distribution phase, both two- and three-compartment models were used to describe the kinetics. The volumes of distribution, intercompartmental clearance rates, and volumes of the central and peripheral compartments were similar. The total body clearance (ClT) of quinidine, 3.58 +/- 1.96 (SD) ml/kg/min, was 56% slower than that of quinine, 8.11 +/- 3.03 ml/kg/min, with p less than 0.02. Quinine half-life (t1/2), 6.58 +/- 3.3 h, was 54% less than that of quinidine, 14.4 +/- 4.10 h, p less than 0.02.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D011803 Quinine An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. Biquinate,Legatrim,Myoquin,Quinamm,Quinbisan,Quinbisul,Quindan,Quinimax,Quinine Bisulfate,Quinine Hydrochloride,Quinine Lafran,Quinine Sulfate,Quinine Sulphate,Quinine-Odan,Quinoctal,Quinson,Quinsul,Strema,Surquina,Bisulfate, Quinine,Hydrochloride, Quinine,Sulfate, Quinine,Sulphate, Quinine
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

D R Clohisy, and T P Gibson
October 1989, Journal of pharmacobio-dynamics,
D R Clohisy, and T P Gibson
March 1993, British journal of clinical pharmacology,
D R Clohisy, and T P Gibson
January 1987, Alcohol (Fayetteville, N.Y.),
D R Clohisy, and T P Gibson
October 1991, British heart journal,
D R Clohisy, and T P Gibson
May 1977, Archives internationales de pharmacodynamie et de therapie,
D R Clohisy, and T P Gibson
March 1991, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
D R Clohisy, and T P Gibson
April 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
D R Clohisy, and T P Gibson
January 1984, Pharmacology,
D R Clohisy, and T P Gibson
January 1950, The American journal of physiology,
D R Clohisy, and T P Gibson
January 1987, Acta Leidensia,
Copied contents to your clipboard!